Bi-aryl meta-pyrimidine inhibitors of kinases
US8604042B2 · kind B2 · utility
26Cited by
69References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2010 |
| Grant date | Dec 10, 2013 |
| Priority date | — |
| Expiry date | Aug 24, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.